Pain Neuroscience Education and Basic Body Awareness Therapy in Women With Chronic Pelvic Pain
Investigation of the Effects of Pain Neuroscience Education and Basic Body Awareness Therapy on Pain, Autonomic Nervous System Responses, and Pelvic Floor Muscle Activity in Women With Chronic Pelvic Pain
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
This randomized controlled trial aims to investigate the effects of Pain Neuroscience Education and Basic Body Awareness Therapy, when added to standard physiotherapy and rehabilitation, on pain, autonomic nervous system responses, and pelvic floor muscle activity in women with chronic pelvic pain. A total of 45 women diagnosed with chronic pelvic pain will be randomly allocated into three groups: (1) standard physiotherapy and rehabilitation, (2) standard physiotherapy plus Pain Neuroscience Education, and (3) standard physiotherapy plus Basic Body Awareness Therapy. The study will assess pain intensity (algometry, NRS, SF-MPQ), pain catastrophizing, autonomic responses (electrodermal activity), pelvic floor muscle activation (EMG), and related psychological, cognitive, and body awareness parameters. Secondary outcomes will include sexual function, quality of life, and patient satisfaction. The aim is to compare two awareness-based interventions-one primarily mind-to-body (Pain Neuroscience Education) and the other body-to-mind (Basic Body Awareness Therapy)-to determine their relative and complementary effects on pain perception and physiological regulation in women with chronic pelvic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
January 9, 2026
December 1, 2025
9 months
November 25, 2025
December 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Pressure Pain Threshold and Pain Tolerance
Pressure pain threshold and tolerance will be assessed using a Baseline® manual algometer. Standardized measurement points will be located in the abdominal and pelvic regions (15 points in total). Pressure will be applied perpendicularly at a rate of 1 kg/s until the participant reports the first pain sensation and maximum tolerable pain. The mean of two measurements per site will be used for analysis. Distal control points (C5-C6 zygapophyseal level, second metacarpal, and tibialis anterior muscle) will be included to evaluate widespread pressure sensitivity as an indicator of central sensitization.
Baseline and up to 8 weeks
Pain Intensity and Characteristics (Short Form McGill Pain Questionnaire)
Pain intensity and characteristics will be assessed using the Short Form McGill Pain Questionnaire (SF-MPQ). The SF-MPQ evaluates both sensory (11 items) and affective (4 items) dimensions of pain through 15 descriptors rated on a 4-point scale (0 = none to 3 = severe). It also includes a Visual Analog Scale (VAS) and a 6-point Likert scale assessing overall pain intensity (0 = no pain to 5 = unbearable pain). Total scores will be calculated for sensory, affective, and overall dimensions.
Baseline and up to 8 weeks
Pain Catastrophizing (Pain Catastrophizing Scale)
Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS), a 13-item self-report questionnaire developed by Sullivan et al. to measure negative cognitive and emotional responses to pain. Each item is rated on a 5-point Likert scale (0 = not at all, 4 = all the time), with total scores ranging from 0 to 52. Higher scores indicate greater levels of catastrophizing. The PCS includes three subscales: rumination, magnification, and helplessness.
Baseline and up to 8 weeks
Autonomic Nervous System Responses - Tonic Skin Conductance Level (SCL)
Resting tonic skin conductance level will be recorded using the Shimmer3 GSR+ device with electrodes placed on the hypothenar region. Higher SCL indicates increased sympathetic arousal.
Baseline and up to 8 weeks
Autonomic Nervous System Responses- Phasic Skin Conductance Response (SCR) Amplitude
Phasic SCR amplitude will be recorded during painful pressure stimuli applied at the Pfannenstiel incision point. This parameter reflects rapid sympathetic responses to pain.
Baseline and up to 8 weeks
Autonomic Nervous System Responses- Skin Conductance Response Frequency
The total number of phasic responses during the stimulus period will be counted to quantify response frequency.
Baseline and up to 8 weeks
Autonomic Nervous System Responses- Skin Conductance Response Latency
Latency from stimulus onset to the first SCR will be measured to assess autonomic response timing.
Baseline and up to 8 weeks
Resting Pelvic Floor Muscle Activity (Resting sEMG) (Surface Electromyography)
Resting pelvic floor muscle activity will be recorded using surface electromyography (NeuroTrac® MyoPlus PRO). Electrodes will be placed bilaterally in the perianal region. Mean resting µV value across trials will be used for analysis.
Baseline and up to 8 weeks
Minimum Pelvic Floor Muscle Activation (Minimum sEMG) (Surface Electromyography)
Minimum muscle activation during contraction attempts will be recorded in µV. The lowest activation value across the contraction-relaxation cycles will be used.
Baseline and up to 8 weeks
Maximum Voluntary Contraction of Pelvic Floor Muscles (MVC) (Surface Electromyography)
MVC will be assessed during five maximal pelvic floor contractions. Values will be expressed as percent activation relative to baseline.
Baseline and up to 8 weeks
Pelvic Floor Muscle Relaxation Time (Surface Electromyography)
Relaxation time will be measured as the time required for sEMG amplitude to return from peak activation to baseline following a contraction.
Baseline and up to 8 weeks
Secondary Outcomes (8)
Pain-Related Beliefs (Pain Beliefs Questionnaire)
Baseline and up to 8 weeks
Pelvic Floor Symptoms (Global Pelvic Floor Bother Questionnaire)
Baseline and up to 8 weeks
Female Sexual Function (Female Sexual Function Index)
Baseline and up to 8 weeks
Depression, Anxiety, and Stress Levels (Depression Anxiety Stress Scale-21)
Baseline and up to 8 weeks
Interoceptive Awareness (Multidimensional Assessment of Interoceptive Awareness II)
Baseline and up to 8 weeks
- +3 more secondary outcomes
Study Arms (3)
Pain Neuroscience Education + Standard Physiotherapy and Rehabilitation
EXPERIMENTALParticipants receive the standard physiotherapy and rehabilitation program in addition to structured Pain Neuroscience Education sessions.
Basic Body Awareness Therapy + Standard Physiotherapy Group
EXPERIMENTALParticipants receive the standard physiotherapy and rehabilitation program in addition to Basic Body Awareness Therapy sessions focusing on posture, movement and breathing.
Standard Physiotherapy and Rehabilitation Group
ACTIVE COMPARATORParticipants receive standard pelvic physiotherapy and rehabilitation interventions, including relaxation training, myofascial release, stretching, breathing, and aerobic exercises.
Interventions
The interventions will be conducted over 8 weeks, with sessions held twice per week. The Standard Physiotherapy and Rehabilitation program includes pelvic floor muscle relaxation, myofascial release, stretching, breathing and relaxation exercises, and aerobic training.
The Pain Neuroscience Education (PNE) group will receive the same physiotherapy program plus weekly educational sessions focused on pain neurophysiology, central sensitization, and cognitive reframing strategies, delivered by a physiotherapist trained in Pain Neuroscience Education.
The Basic Body Awareness Therapy (BBAT) group will receive the same physiotherapy program plus weekly body awareness sessions emphasizing postural alignment, movement control and breathing. Exercises will be practiced in supine, sitting, and standing positions to enhance body-mind awareness. All interventions will be supervised by an experienced pelvic floor physiotherapist at Istinye University.
Eligibility Criteria
You may qualify if:
- Women with any type of chronic pelvic pain, including pelvic floor muscle dysfunction, endometriosis, vulvodynia, genito-pelvic pain/penetration disorder, or bladder pain syndrome, with pain persisting for six months or longer.
You may not qualify if:
- Presence of pelvic infections, inflammatory conditions, or pelvic malignancy.
- Pregnancy.
- History of urogynecological surgery within the last six months.
- Presence of advanced pelvic organ prolapse.
- Patients currently receiving chemotherapy or radiotherapy.
- Patients whose primary complaint is not chronic pelvic pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sena Öndeşlead
- Istinye Universitycollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
November 25, 2025
First Posted
January 9, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
January 9, 2026
Record last verified: 2025-12